Scientific corner

Predictive factors of clinical response in steroid-refractory ulcerative colitis treated with granulocyte-monocyte apheresis

Valeria D’Ovidio 1Donatella MeoAngelo ViscidoGiampaolo BresciPiero VerniaRenzo Caprilli, World J Gastroenterol. 2011 Apr 14;17(14):1831-5.

GMA may be a valid therapeutic option for steroid-dependent ulcerative colitis patients with mild-moderate disease and its clinical efficacy seems to persist for 12 months.

Contact UsFor more information

Contact Us